Summary:
Neuromod Devices has expanded the availability of its clinically proven Lenire tinnitus treatment device through 19 new clinical partnerships across Europe, significantly increasing patient access.
Key Takeaways:
- The expansion brings Lenire to more clinics in Ireland, Spain, Italy, Belgium, Switzerland, Austria, and the UK.
- Clinical trials and real-world studies show Lenire provides long-term tinnitus relief for the majority of patients.
- Leading tinnitus care providers, such as Harley Street Hearing, report positive outcomes and improved patient management with Lenire.
Neuromod Devices, a technology company that specializes in medical devices for tinnitus treatment, has announced 19 new clinical partnerships to expand the availability of the Lenire tinnitus treatment device in Europe.
This latest expansion will significantly increase the number of clinics providing Lenire in Ireland, Spain, Italy, Belgium, Switzerland, Austria, and the United Kingdom, according to the company.
“Tinnitus is one of the largest unmet needs in hearing healthcare and the prevalence of tinnitus is growing worldwide,” says Dr Ross O’Neill, Neuromod Devices founder and CEO. “These partnerships ensure that European tinnitus patients have access to a proven tinnitus treatment option with guidance from leading tinnitus care professionals.”
Approximately 65 million people are living with tinnitus in Europe.
Jordon Thompson, partner at Harley Street Hearing & Musicians’ Hearing Services, a new clinical partner based in London, spoke about the impact that Lenire has had on the clinic’s tinnitus patients.
“Harley Street Hearing & Musicians’ Hearing Services has been supporting tinnitus patients for over 25 years,” said Thompson, clinical lead. “We introduced Lenire into our practice nearly a year ago, and with Neuromod’s support our team quickly built confidence in this advanced technology. We are already seeing successful outcomes that are helping patients manage tinnitus more effectively.”
Lenire is a bimodal neuromodulation device which has been proven to provide long lasting relief from tinnitus in multiple large-scale clinical trials. Lenire treats tinnitus through a combination of auditory and tongue stimulation that retrains the brain to significantly reduce tinnitus focus.
Lenire has been proven safe and effective in clinical trials in three large-scale clinical trials that featured more than 600 patients.
Lenire is now available through hearing and tinnitus care clinics across Europe. Tinnitus patients can find a nearby clinic and book an appointment by visiting www.lenire.com/find-a-clinic.
Featured image: Neuromod Devices
